In vivo binding of complement regulator factor H by Streptococcus pneumoniae

Journal of Infectious Diseases

Volumn 192, Issue 11, 2005, Pages 1996-2003

  Quin, Lisa R ^a   Carmicle, Stephanie ^a   Dave, Sandhya ^a,c   Pangburn, Michael K ^b   Evenhuis, Jason P ^a   McDaniel, Larry S ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; COMPLEMENT REGULATOR FACTOR H; MESSENGER RNA; MONOCLONAL ANTIBODY; PROTEIN PSPC; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; BINDING AFFINITY; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; STREPTOCOCCUS PNEUMONIAE; SYSTEMIC DISEASE;

ANIMALS; BACTEREMIA; BACTERIAL PROTEINS; COMPLEMENT FACTOR H; FLOW CYTOMETRY; HUMANS; MICE; MICE, INBRED CBA; PNEUMOCOCCAL INFECTIONS; RNA, MESSENGER; STREPTOCOCCUS PNEUMONIAE;

EID: 27944505853     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/497605     Document Type: Article

References (42)

1. McDaniel LS, Swiatlo E. Pneumococcal disease: pathogenesis, treatment, and prevention. Infect Dis Clin Pract 2004; 12:93-98.
2. Abeyta M, Hardy GG, Yother J. Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae. Infect Immun 2003; 71: 218-25.
3. Bosarge JR, Watt JM, McDaniel DO, Swiatlo E, McDaniel LS. Genetic immunization with the region encoding the alpha-helical domain of PspA elicits protective immunity against Streptococcus pneumoniae. Infect Immun 2001; 69:5456-63.
4. Swaitlo E, McDaniel LS, Briles DE. Choline binding proteins. In: Tuomanen E, ed. The pneumococcus. Washington, DC: ASM Press, 2004: 49-60.
5. Dave S, Pangburn MK, Pruitt C, McDaniel LS. Interaction of human factor H with PspC of Streptococcus pneumoniae. Indian J Med Res 2004; 119(Suppl):66-73.
6. Rosenow C, Ryan P, Weiser JN, et al. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol Microbiol 1997; 25:819-29.
7. Hammerschmidt S, Talay SR, Brandtzaeg P, Chhatwal GS. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol Microbiol 1997;25: 1113-24.
8. Rogers PD, Thornton J, Barker KS, et al. Pneumolysin-dependent and -independent gene expression identified by cDNA microarray analysis of THP-1 human mononuclear cells stimulated by Streptococcus pneumoniae. Infect Immun 2003; 71:2087-94.
9. Jarva H, Jokiranta TS, Wurzner R, Meri S. Complement resistance mechanisms of streptococci. Mol Immunol 2003; 40:95-107.
10. Ren B, Szalai AJ, Hollingshead SK, Briles DE. Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface. Infect Immun 2004; 72:114-22.
11. Morgan BP. The complement system: an overview. In: Morgan BP, ed. Complement methods and protocols. Totowa, NJ: Humana Press, 2000: 1-13.
12. Pickering MC, Cook HT, Warren J, et al. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet 2002; 31:424-8.
13. Jozsi M, Manuelian T, Heinen S, Oppermann M, Zipfel PF. Attachment of the soluble complement regulator factor H to cell and tissue surfaces: relevance for pathology. Histol Histopathol 2004; 19:251-8.
14. Krushkal J, Bat O, Gigli I. Evolutionary relationships among proteins encoded by the regulator of complement activation gene cluster. Mol Biol Evol 2000; 17:1718-30.
15. Rodriguez De Cordoba S, Esparza-Gordillo J, Goicoechea De Jorge E, Lopez-Trascasa M, Sanchez-Corral P. The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 2004; 41:355-67.
16. Zipfel PF, Skerka C, Hellwage J, et al. Factor H family proteins: on complement, microbes and human diseases. Biochem Soc Trans 2002; 30:971-8.
17. Pangburn MK, Pangburn KL, Koistinen V, Meri S, Sharma AK. Molecular mechanisms of target recognition in an innate immune system: interactions among factor H, C3b, and target in the alternative pathway of human complement. J Immunol 2000; 164:4742-51.
18. Fedarko NS, Fohr B, Robey PG, Young MF, Fisher LW. Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack. J Biol Chem 2000; 275:16666-72.
19. Blackmore TK, Fischetti VA, Sadlon TA, Ward HM, Gordon DL. M protein of the group A Streptococcus binds to the seventh short consensus repeat of human complement factor H. Infect Immun 1998; 66:1427-31.
20. Dave S, Brooks-Walter A, Pangburn MK, McDaniel LS. PspC, a pneumococcal surface protein, binds human factor H. Infect Immun 2001; 69:3435-7.
21. Dave S, Carmicle S, Hammerschmidt S, Pangburn MK, McDaniel LS. Dual roles of PspC, a surface protein of Streptococcus pneumoniae, in binding human secretory IgA and factor H. J Immunol 2004; 173:471-7.
22. Brooks-Walter A, Briles DE, Hollingshead SK. The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia. Infect Immun 1999; 67:6533-42.
23. Iannelli F, Oggioni MR, Pozzi G. Allelic variation in the highly polymorphic locus pspC of Streptococcus pneumoniae. Gene 2002; 284:63-71.
24. Balachandran P, Brooks-Walter A, Virolainen-Julkunen A, Hollingshead SK, Briles DE. Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae. Infect Immun 2002; 70: 2526-34.
25. Iannelli F, Chiavolini D, Ricci S, Oggioni MR, Pozzi G. Pneumococcal surface protein C contributes to sepsis caused by Streptococcus pneumoniae in mice. Infect Immun 2004; 72:3077-80.
26. Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004; 4:144-54.
27. Smith BL, Hosteller MK. C3 as substrate for adhesion of Streptococcus pneumoniae. J Infect Dis 2000; 182:497-508.
28. McDaniel LS, Sheffield JS, Delucchi P, Briles DE. PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type. Infect Immun 1991; 59: 222-8.
29. McDaniel LS, Scott G, Kearney JF, Briles DE. Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae. J Exp Med 1984; 160:386-97.
30. Yother J, Forman C, Gray BM, Briles DE. Protection of mice from infection with Streptococcus pneumoniae by anti-phosphocholine antibody. Infect Immun 1982; 36:184-8.
31. Ogunniyi AD, Giammarinaro P, Paton JC. The genes encoding virulence-associated proteins and the capsule of Streptococcus pneumoniae are upregulated and differentially expressed in vivo. Microbiology 2002; 148:2045-53.
32. McDaniel LS, Benjamin WH Jr, Forman C, Briles DE. Blood clearance by anti-phosphocholine antibodies as a mechanism of protection in experimental pneumococcal bacteremia. J Immunol 1984; 133:3308-12.
33. ΔΔCT method. Methods 2001; 25: 402-8.
34. Stevenson B, El-Hage N, Hines MA, Miller JC, Babb K. Differential binding of host complement inhibitor factor H by Borrelia burgdorferi Erp surface proteins: a possible mechanism underlying the expansive host range of Lyme disease spirochetes. Infect Immun 2002; 70:491-7.
35. Pandiripally V, Wei L, Skerka C, Zipfel PF, Cue D. Recruitment of complement factor H-like protein 1 promotes intracellular invasion by group A streptococci. Infect Immun 2003; 71:7119-28.
36. Kraiczy P, Hellwage J, Skerka C, et al. Immune evasion of Borrelia burgdorferi: mapping of a complement-inhibitor factor H-binding site of BbCRASP-3, a novel member of the Erp protein family. Eur J Immunol 2003; 33:697-707.
37. Ram S, Sharma AK, Simpson SD, et al. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J Exp Med 1998; 187:743-52.
38. Jarva H, Janulczyk R, Hellwage J, Zipfel PF, Bjorck L, Meri S. Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hk protein that binds to short consensus repeats 8-11 of factor H. J Immunol 2002; 168:1886-94.
39. Orihuela CI, Radin JN, Sublett JE, Gao G, Kaushal D, Tuomanen EI. Microarray analysis of pneumococcal gene expression during invasive disease. Infect Immun 2004; 72:5582-96.
40. Magee AD, Yother J. Requirement for capsule in colonization by Streptococcus pneumoniae. Infect Immun 2001; 69:3755-61.
41. Elm C, Braathen R, Bergmann S, et al. Ectodomains 3 and 4 of human polymeric immunoglobulin receptor (hpIgR) mediate invasion of Streptococcus pneumoniae into the epithelium. J Biol Chem 2004; 279: 6296-304.
42. Hava DL, LeMieux J, Camilli A. From nose to lung: the regulation behind Streptococcus pneumoniae virulence factors. Mol Microbiol 2003; 50:1103-10.